Healthcare · NIFTY 500
Syngene International Limited
₹449.00 +6.15 (+1.39%) Updated 12 Nov, 8:49 pm IST
Today
- Open
- ₹447.00
- Prev close
- ₹442.85
- Day high
- ₹449.50
- Day low
- ₹441.00
- Volume
- 5.46 L
- Value traded
- ₹24.37 Cr
- Upper circuit
- ₹531.40
- Lower circuit
- ₹354.30
- 52W high
- ₹678.95
- 52W low
- ₹344.45
- 1 month
- +20.01%
- 6 months
- -13.94%
Ratios
Key numbers
Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.
Quarterly results
Results for each quarter
Last 12 quarters, consolidated, ₹ crore. Hover a bar to see the number.
Revenue and net profit
Revenue · QoQ (vs last quarter)
Revenue · YoY (vs a year ago)
Net profit · QoQ (vs last quarter)
Net profit · YoY (vs a year ago)
EPS (₹) · YoY (vs a year ago)
| ₹ Cr | Dec 23 | Mar 24 | Jun 24 | Sep 24 | Dec 24 | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 854 | 917 | 790 | 891 | 944 | 1,018 | 875 | 911 | 917 | 1,037 | 736 | 833 |
| Other income | 29.3 | 16.1 | 18.1 | 16.5 | 18.3 | 18.9 | 17.7 | 15.4 | 15.4 | 22.2 | 25.3 | 28.0 |
| Total income | 883 | 933 | 808 | 908 | 962 | 1,037 | 892 | 926 | 933 | 1,059 | 761 | 861 |
| Raw material | 240 | 172 | 168 | 231 | 242 | 228 | 240 | 228 | 221 | 223 | 178 | 203 |
| Purchases | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Employee cost | 221 | 227 | 230 | 252 | 250 | 253 | 262 | 275 | 267 | 301 | 259 | 273 |
| Other expenses | 164 | 170 | 157 | 158 | 173 | 186 | 189 | 198 | 211 | 199 | 213 | 214 |
| Total expenses | 741 | 724 | 739 | 770 | 781 | 796 | 791 | 841 | 834 | 857 | 767 | 807 |
| Operating profit | 228 | 317 | 202 | 245 | 284 | 344 | 206 | 200 | 139 | 297 | 77.3 | 141 |
| OPM % | 26.7% | 34.6% | 25.6% | 27.5% | 30.1% | 33.8% | 23.6% | 21.9% | 15.1% | 28.7% | 10.5% | 16.9% |
| Finance cost | 10.8 | 12.9 | 11.7 | 13.1 | 12.4 | 15.9 | 11.6 | 13.2 | 11.9 | 12.1 | 9.6 | 10.0 |
| Depreciation | 108 | 111 | 107 | 111 | 109 | 106 | 111 | 117 | 114 | 112 | 112 | 112 |
| Exceptional items | -3.7 | — | 32.0 | — | — | — | — | — | -70.6 | -6.0 | -13.5 | -6.7 |
| Profit before tax | 138 | 209 | 101 | 137 | 181 | 241 | 101 | 85.2 | 28.4 | 196 | -19.2 | 47.0 |
| Tax | 26.7 | 20.4 | 25.6 | 31.2 | 49.7 | 57.2 | 14.6 | 18.1 | 13.4 | 48.1 | -10.2 | 14.8 |
| Net profit | 112 | 189 | 75.7 | 106 | 131 | 183 | 86.7 | 67.1 | 15.0 | 148 | -9.0 | 32.2 |
| Profit to shareholders | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | — | — |
| EPS (₹) | 2.77 | 4.69 | 1.88 | 2.64 | 3.26 | 4.56 | 2.15 | 1.67 | 0.37 | 3.67 | -0.22 | 0.80 |
Profit & loss
Results for each year
8 financial years (April to March), consolidated, ₹ crore.
Sales, operating profit and net profit
Revenue · YoY (vs a year ago)
Net profit · YoY (vs a year ago)
| ₹ Cr | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1,826 | 2,012 | 2,184 | 2,604 | 3,193 | 3,489 | 3,642 | 3,739 |
| Other income | 75.1 | 81.6 | 64.6 | 52.8 | 70.9 | 90.6 | 71.8 | 70.7 |
| Total expenses | 1,485 | 1,648 | 1,815 | 2,142 | 2,670 | 2,947 | 3,086 | 3,322 |
| Employee cost | 473 | 580 | 660 | 718 | 842 | 889 | 984 | 1,105 |
| Operating profit | 537 | 689 | 707 | 765 | 934 | 1,003 | 1,074 | 842 |
| OPM % | 29.4% | 34.3% | 32.4% | 29.4% | 29.3% | 28.8% | 29.5% | 22.5% |
| Finance cost | 32.3 | 34.6 | 27.7 | 24.1 | 45.2 | 47.2 | 53.1 | 48.8 |
| Depreciation | 164 | 219 | 275 | 310 | 367 | 426 | 433 | 453 |
| Profit before tax | 415 | 517 | 469 | 484 | 594 | 621 | 660 | 411 |
| Tax | 83.8 | 105 | 64.3 | 88.6 | 129 | 111 | 164 | 94.2 |
| Tax rate % | 20.2% | 20.3% | 13.7% | 18.3% | 21.8% | 17.8% | 24.8% | 22.9% |
| Net profit | 332 | 412 | 405 | 396 | 464 | 510 | 496 | 317 |
| Profit to shareholders | — | 0.0 | — | 0.0 | 0.0 | — | 0.0 | 0.0 |
| Net margin % | 18.2% | 0.0% | 18.5% | 0.0% | 0.0% | 14.6% | 0.0% | 0.0% |
| EPS (₹) | 16.72 | 10.35 | 10.11 | 9.82 | 11.51 | 12.69 | 12.34 | 7.87 |
Balance sheet
Assets and debt
At each year end (and the latest half year), ₹ crore.
Equity, debt and assets
Shareholders' equity · YoY (vs a year ago)
| ₹ Cr | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Sep 26 |
|---|---|---|---|---|---|
| Shareholders' equity | 3,618 | 4,258 | 4,727 | 4,839 | 4,859 |
| Long-term borrowings | 489 | 100 | 0.0 | 0.0 | 0.0 |
| Short-term borrowings | 86.3 | 41.7 | 120 | 9.4 | 67.2 |
| Total borrowings | 575 | 142 | 120 | 9.4 | 67.2 |
| Current liabilities | 1,188 | 1,144 | 1,396 | 1,552 | 1,183 |
| Fixed assets (PPE) | 2,383 | 2,378 | 2,323 | 2,545 | 2,448 |
| Inventories | 333 | 239 | 156 | 141 | 168 |
| Trade receivables | 529 | 442 | 527 | 509 | 386 |
| Cash & equivalents | 89.5 | 85.7 | 367 | 229 | 120 |
| Current assets | 2,425 | 1,959 | 2,287 | 2,143 | 1,948 |
| Total assets | 5,831 | 6,152 | 6,796 | 7,055 | 6,659 |
| Debt / equity | 0.16 | 0.03 | 0.03 | 0.00 | 0.01 |
Cash flow
Cash coming in and going out
For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.
Operating, investing and financing cash
Operations · YoY (vs a year ago)
| ₹ Cr | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash from operations | 581 | 824 | 1,042 | 1,168 | 915 |
| Cash from investing | -612 | -656 | -496 | -745 | -860 |
| Cash from financing | -31.3 | -343 | -551 | -142 | -215 |
| Spent on fixed assets | -475 | -507 | -492 | -760 | -344 |
| Free cash flow | 105 | 317 | 550 | 407 | 571 |
| Net cash flow | -62.2 | -175 | -4.9 | 281 | -160 |
Shareholding
Who holds the shares
Promoter and public holding at each quarter end, as filed with NSE.
Holding over time
Latest (30 Sep 2026)
- Promoter & group
- 52.59%
- Public (FIIs, mutual funds, retail…)
- 47.00%
- Employee trusts
- 0.41%
- Promoter change, last quarter
- 0.00 pts
Dividends & news
Latest dividends and announcements
Dividends & corporate actions
- Dividend - Rs 1.25 Per Share
- Dividend - Rs 1.25 Per Share
- Dividend - Rs 1.25 Per Share
- Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.75 Per Share
- Dividend - Rs 0.50 Per Share/Special Dividend - Rs 0.50 Per Share
- Annual General Meeting
- Dividend - Rs 0.50 Per Share
- Bonus 1:1
Board meetings
- SYNGENE INTERNATIONAL LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2026 to inter-alia consider and approve the Unaudite…
- the financial results for the period ended September 30, 2026
- SYNGENE INTERNATIONAL LIMITED has informed the Exchange about Board Meeting to be held on 29-Jul-2026 to inter-alia consider and approve the Unaudite…
- the financial results for the period ended Jun 30, 2026
- the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend.
Filings with NSE
- Analysts/Institutional Investor Meet/Con. Call Updates
- Copy of Newspaper Publication
- Analysts/Institutional Investor Meet/Con. Call Updates
- Investor Presentation
- Resignation of Director/KMP/SMP
- Press Release
- Change in Management
Latest news
SYNGENE Outlook for the WeekEquitypandit · 8 Nov, 1:30 pmVolumes spurt at Syngene International Ltd counterBusiness Standard · 20 Aug, 12:30 pmSyngene International (NSEI:SYNGENE) Stock Forecast & Analyst PredictionsSimply Wall St · 29 Oct, 12:30 pmSyngene International shares surge 12%, biggest 1-day gain in 6 years; what drove the rally despite a Q2 profit drop?Livemint · 28 Oct, 12:30 pmSYNGENE INTERNATIONAL Share Price Today Down 5%Equitymaster · 21 Oct, 12:30 pmSyngene shares jump 17% after Q4 results; check Macquarie price targetCNBC TV18 · 30 Apr, 12:30 pmSyngene International Shares Slide 8% After Q1 Swings To Loss, Revenue Misses EstimatesNDTV Profit · 30 Jul, 12:30 pmSyngene International Share Price News After 5.43% DropUnivest · 21 Oct, 12:30 pmAbout
About Syngene International Limited
Syngene International Limited is listed on the NSE under the symbol SYNGENE and belongs to the Healthcare sector.
Company details
- Company name
- Syngene International Limited
- NSE symbol
- SYNGENE
- BSE scrip code
- 539268
- ISIN
- INE398R01022
- Listed on
- NSE, BSE
- Series
- EQ (normal equity)
- Listed on NSE since
- 11 Aug 2015
- Face value
- ₹10 per share
- Market lot
- 1 share
- Shares issued
- 40.37 crore
- Index
- NIFTY 500
- Sector (NSE)
- Healthcare
- Industry
- Miscellaneous Commercial Services
- Managing director / CEO
- Siddarth Mittal
- Chair
- Kiran Mazumdar Shaw
- Headquarters
- Bengaluru, Karnataka, India
- Registered address
- The Hub', Tower 8A, 360 Degree Business Park, Doddathoguru, Electronic City, Phase 1, Bengaluru, Karnataka 560100
- Founded
- 1993
- Employees
- 8,376
- Financial year
- April to March
- Results basis
- Consolidated
- Website
- syngeneintl.com
Peers
Other Healthcare stocks
-
DIVISLABDivi's Laboratories ₹11,485.00 +1.04%
-
ALKEMAlkem Laboratories ₹5,302.00 -2.68%
-
GRANULESGranules India ₹840.50 +5.16%
-
SUNPHARMASun Pharmaceutical Industries ₹1,885.00 -0.91%
-
LAURUSLABSLaurus Labs ₹2,400.00 -1.19%
-
AUROPHARMAAurobindo Pharma ₹1,807.20 -1.11%
-
ACUTAASAcutaas Chemicals ₹3,996.10 +2.02%
-
APOLLOHOSPApollo Hospitals Enterprise ₹8,515.00 -1.03%
Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.